{"id":78262,"date":"2021-12-08T10:30:00","date_gmt":"2021-12-08T09:30:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=78262"},"modified":"2021-12-08T09:56:48","modified_gmt":"2021-12-08T08:56:48","slug":"visionhealth-asthma-study","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/78262\/visionhealth-asthma-study\/","title":{"rendered":"Visionhealth supports Sterna Biologicals in asthma study"},"content":{"rendered":"
\n

Sterna<\/a> is a clinical-stage immunology company developing novel biological treatments for chronic inflammatory diseases. The current study is designed to evaluate the safety and efficacy of its lead drug candidate, SB010, for the treatment of asthma. With its Kata Clinical application, the company supports Munich startup Visionhealth<\/a> Sterna in this project.<\/p>\n\n\n\n

The app is designed for pharmaceutical, biotech, and CRO partners to support clinical trials on respiratory diseases. For Sterna's asthma study, Visionhealth has adapted Kata Clinical to specifically support the run-in phase for patient preparation and treatment adherence, as well as ensuring correct inhalation with SB010. Furthermore, the app is intended to support daily monitoring and management of disease and safety parameters such as asthma symptoms, peak flow values, and (Editor's note: lung function values)<\/em> and monitor emergency medication.<\/p>\n\n\n\n

Chronic respiratory diseases such as asthma are typically treated with inhaled medications. The inhalation process is prone to errors. Not only the treatment, but also the results of clinical trials depend to a large extent on the correct use of inhalers and the resulting, correct dosage of medication.<\/p>\n\n\n\n

Important milestone<\/h2>\n\n\n\n

Dr. Sabine H\u00e4u\u00dfermann, <\/strong>CEO and founder of Visionhealth, says:<\/p>\n\n\n\n

"The integration of Kata Clinical into Sterna's study is an important milestone, but also an important validation of our technology and business model. We are convinced that the study will have concrete benefits thanks to Kata Clinical: Through correct inhaler use, patients receive the intended dose of medication in the lungs. This leads to valid data. It also simplifies data management overall."<\/p><\/blockquote>\n\n\n\n

And Dr. Marion Wencker,<\/strong> Chief Scientific Officer at Sterna Biologicals, continues:<\/p>\n\n\n\n

"We are delighted to collaborate with Visionhealth and use Kata Clinical in our proof-of-concept study for SB010 in asthma. Kata Clinical is like a versatile 'jackknife' for clinical trials in respiratory indications. To adapt the app to our study, we selected the features that best support us in conducting comprehensive data collection and analysis through integrated questionnaires and patient diaries. We are confident that we can increase data validity by minimizing inhaler errors: Kata Clinical supports our study participants with a fascinating combination of artificial intelligence and computer animation."<\/p><\/blockquote>\n\n\n\n

<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Visionhealth helps patients with chronic lung disease use their inhalation therapy more effectively. With its Kata Clinical app, the Munich-based startup is now supporting Sterna Biologicals (Sterna) in a proof-of-concept study with patients with moderate to severe asthma.<\/p>","protected":false},"author":24,"featured_media":46570,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5638,1],"tags":[3556],"acf":[],"yoast_head":"\nVisionhealth unterst\u00fctzt Sterna Biologicals bei Asthmastudie<\/title>\n<meta name=\"description\" content=\"Visionhealth unterst\u00fctzt Sterna Biologicals in einer Proof-of-Concept-Studie bei PatientInnen mit moderatem bis schwerem Asthma.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/78262\/visionhealth-asthma-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Visionhealth unterst\u00fctzt Sterna Biologicals bei Asthmastudie\" \/>\n<meta property=\"og:description\" content=\"Visionhealth unterst\u00fctzt Sterna Biologicals in einer Proof-of-Concept-Studie bei PatientInnen mit moderatem bis schwerem Asthma.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/78262\/visionhealth-asthma-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-08T09:30:00+00:00\" \/>\n<meta name=\"author\" content=\"Regina Bruckschl\u00f6gl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Regina Bruckschl\u00f6gl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/\",\"url\":\"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/\",\"name\":\"Visionhealth unterst\u00fctzt Sterna Biologicals bei Asthmastudie\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg\",\"datePublished\":\"2021-12-08T09:30:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\"},\"description\":\"Visionhealth unterst\u00fctzt Sterna Biologicals in einer Proof-of-Concept-Studie bei PatientInnen mit moderatem bis schwerem Asthma.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg\",\"width\":2000,\"height\":855,\"caption\":\"VisionHealth\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Visionhealth unterst\u00fctzt Sterna Biologicals bei Asthmastudie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\",\"name\":\"Regina Bruckschl\u00f6gl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"caption\":\"Regina Bruckschl\u00f6gl\"},\"description\":\"Nach eigenen Startup-Erfahrungen blickt sie als Redakteurin von Munich Startup nun aus einer anderen Perspektive auf die M\u00fcnchner Startup-Szene \u2013 und entdeckt dabei jeden Tag, wie vielf\u00e4ltig das M\u00fcnchner \u00d6kosystem ist. Startup Stories, die erz\u00e4hlt werden wollen!\",\"sameAs\":[\"https:\/\/cms.munich-startup.net\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/regina\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"855\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Visionhealth supports Sterna Biologicals in asthma study","description":"Visionhealth is supporting Sterna Biologicals in a proof-of-concept study in patients with moderate to severe asthma.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/78262\/visionhealth-asthma-study\/","og_locale":"en_US","og_type":"article","og_title":"Visionhealth unterst\u00fctzt Sterna Biologicals bei Asthmastudie","og_description":"Visionhealth unterst\u00fctzt Sterna Biologicals in einer Proof-of-Concept-Studie bei PatientInnen mit moderatem bis schwerem Asthma.","og_url":"https:\/\/cms.munich-startup.net\/en\/78262\/visionhealth-asthma-study\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2021-12-08T09:30:00+00:00","author":"Regina Bruckschl\u00f6gl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Regina Bruckschl\u00f6gl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/","url":"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/","name":"Visionhealth supports Sterna Biologicals in asthma study","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg","datePublished":"2021-12-08T09:30:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f"},"description":"Visionhealth is supporting Sterna Biologicals in a proof-of-concept study in patients with moderate to severe asthma.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg","width":2000,"height":855,"caption":"VisionHealth"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/78262\/visionhealth-asthmastudie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Visionhealth unterst\u00fctzt Sterna Biologicals bei Asthmastudie"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f","name":"Regina Bruckschl\u00f6gl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","caption":"Regina Bruckschl\u00f6gl"},"description":"After her own startup experiences, she now looks at the Munich startup scene from a different perspective as an editor at Munich Startup \u2013 and discovers every day how diverse the Munich ecosystem is. Startup stories that beg to be told!","sameAs":["https:\/\/cms.munich-startup.net"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/regina\/"}]},"og_image":[{"width":2000,"height":855,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/03\/VisionHealth_Team_Kern-e1553790317940.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1638956388:24","_edit_last":"33","_yoast_wpseo_focuskw":"Visionhealth","_yoast_wpseo_metadesc":"Visionhealth unterst\u00fctzt Sterna Biologicals in einer Proof-of-Concept-Studie bei PatientInnen mit moderatem bis schwerem Asthma.","_yoast_wpseo_linkdex":"73","_thumbnail_id":"46570","wbounce_status":"default","_yoast_wpseo_primary_category":"5638","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"60","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"%%title%% %%page%%","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/78262"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=78262"}],"version-history":[{"count":4,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/78262\/revisions"}],"predecessor-version":[{"id":78270,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/78262\/revisions\/78270"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/46570"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=78262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=78262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=78262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}